secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evofem Biosciences, Inc. (EVFM)
CIK:        0001618835
Form:       8-K
Filed at:   2025-04-14T23:59:59+00:00
Accession:  0001641172-25-004599
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evofem issues $1.15M convertible notes to Aditxt as part of merger financing
----------------------------------------------------------------------------

- Issued $1,153,846 principal in senior subordinated convertible notes and warrants to buy 74,925,075 shares to Aditxt.
- Net proceeds of ~$750,000 from partial close on April 8; Aditxt paid $650 per $1,000 principal.
- Notes bear 8% interest (12% default), mature April 8, 2028, convertible at $0.0154 per share; warrants at same price.
- Waived Aditxt default for missing $1.5M Fifth Parent Investment; second half must close by April 16 or merger can end.
- Aditxt obtained call option from Adjuvant to buy convertible notes for $13M, contingent on senior debt satisfaction.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1618835/000164117225004599/0001641172-25-004599-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1618835/000164117225004599/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-004599

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer